How drug company money turned patient groups into “cheerleaders for opioids”

How drug company money turned patient groups into “cheerleaders for opioids” The five biggest opioid manufacturers shelled out more than $10 million to patient advocacy groups, professional medical societies and affiliated individuals — who then “echoed and amplified” messages that encouraged use of those highly addictive drugs and set the […]